Comparative clinical response, safety, and institutional drug use efficiency of intravenous azithromycin versus erythromycin in pediatric Mycoplasma pneumoniae pneumonia: a real-world evidence study
ObjectiveThis study aims to compare real-world clinical response, safety, and institutional medication efficiency of intravenous (IV) azithromycin (AZI) versus erythromycin lactobionate (ERY) in hospitalized children with Mycoplasma pneumoniae pneumonia (MPP).MethodsA retrospective cohort of 1,049 c...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2026-02-01
|
| Serie: | Frontiers in Cellular and Infection Microbiology |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fcimb.2026.1782840/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
